Evidence supporting the use of: Fish oil
For the health condition: Blood Clots (prevention of)

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Fish oil, rich in omega-3 fatty acids such as EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), has been scientifically investigated for its effects on blood clot prevention. Multiple studies have shown that omega-3 fatty acids can reduce platelet aggregation, lower blood viscosity, and decrease levels of certain clotting factors in the blood. These effects theoretically reduce the risk of thrombosis (blood clot formation). Clinical trials and epidemiological studies have demonstrated that populations with higher fish or fish oil consumption tend to have lower rates of cardiovascular events, some of which are related to blood clots. However, while the biochemical effects of fish oil on clotting mechanisms are well-documented, the direct evidence supporting its use specifically for primary prevention of blood clots (such as deep vein thrombosis or pulmonary embolism) in the general population is moderate rather than strong.

Recent large-scale clinical trials have yielded mixed results regarding fish oil’s effectiveness in preventing major cardiovascular events, which often involve clotting. Some guidelines suggest fish oil supplementation for certain at-risk populations, but not specifically as a primary antithrombotic agent. Nonetheless, the mechanism by which fish oil may reduce clot formation is scientifically validated, and it is sometimes recommended as part of a broader strategy for cardiovascular health. As with any supplement, its use should be considered in the context of overall risk factors, and patients on anticoagulant medications should consult healthcare providers due to potential interactions.

More about fish oil
More about Blood Clots (prevention of)